We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance to hospital blood banks (HBBs) on flexible approaches to requirements
BBVU offers laboratory reference services and carries out research and development on hepatitis viruses, and has a remit for blood safety.
TACO is one of the most common causes of transfusion-related deaths in the UK and cases have increased substantially in recent years. Identifying risk factors for TACO prior to transfusion allows initiation of appropriate mitigating measures.
NHS Blood and Transplant (NHSBT) is responsible for the supply of blood, organs, tissues and stem cells. It collects and supplies blood to hospitals in England and is the organ donation organisation for the UK. NHSBT is a special health...
What blood establishments, blood banks and manufacturers of blood products need to do to ensure the safety and quality of blood and blood products.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
You must tell DVLA about a blood clot on the brain - download the correct form to let them know
Information and service documents on the national DBS testing service offered by PHE to improve uptake of 12 month testing of infants born to hepatitis B infected mothers.
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
An update on the Infected Blood Compensation body and Victims and Prisoners Bill.
The Infected Blood Compensation Authority (IBCA) will deliver the Infected Blood Compensation Scheme, which will provide financial compensation to victims of infected blood on a UK-wide basis. The Scheme responds to the recommendations made by the Infected Blood Inquiry in...
The epidemiology, symptoms, diagnosis and management of severe fever with thrombocytopaenia syndrome (SFTS).
Form to apply for a blood establishment authorisation and guidance on completing the form.
Information and guidance on a range of medical devices for users and patients.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (30 January 2024) approved the medicine momelotinib (Omjjara) to treat the symptoms experienced by adult myelofibrosis patients who have moderate or severe anaemia (a low number of red blood cells...
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (6 March 2024) approved the Rubidium (Rb82) Generator (RUBY-FILL) as a diagnostic tool for imaging of the heart, to evaluate blood flow and aid in the diagnosis or assessment of...
The UKBTS is run by the Joint Professional Advisory Committee and is responsible for the dissemination of guidance and best practice on blood transfusion.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).